Sinco Pharmaceuticals Holdings Limited

Sinco Pharmaceuticals Holdings Limitedverified

6833.HK

Price:

$0.182

Market Cap:

$334.39M

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-surgery infections; and Medocef that is used for the treatment of bacterial infections, such as the infections of the lower respiratory tract comprisi...[Read more]

Industry

Advertising Agencies

IPO Date

2016-03-10

Stock Exchange

HKSE

Ticker

6833.HK

The PE Ratio as of December 2025 (TTM) for Sinco Pharmaceuticals Holdings Limited (6833.HK) is 9.10

According to Sinco Pharmaceuticals Holdings Limited’s latest financial reports and current stock price. The company's current PE Ratio is 9.10. This represents a change of 95.75% compared to the average of 4.65 of the last 4 quarters.

Sinco Pharmaceuticals Holdings Limited (6833.HK) Historical PE Ratio (quarterly & annually)

How has 6833.HK PE Ratio performed in the past?

The mean historical PE Ratio of Sinco Pharmaceuticals Holdings Limited over the last ten years is 11.59. The current 9.10 PE Ratio has changed 7.75% with respect to the historical average. Over the past ten years (40 quarters), 6833.HK's PE Ratio was at its highest in in the December 2022 quarter at 16.65. The PE Ratio was at its lowest in in the December 2016 quarter at -17.01.

Quarterly (TTM)
Annual

Average

11.59

Median

9.74

Minimum

-5.79

Maximum

39.03

Sinco Pharmaceuticals Holdings Limited (6833.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sinco Pharmaceuticals Holdings Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 456.80%

Maximum Annual PE Ratio = 39.03

Minimum Annual Increase = -1315.19%

Minimum Annual PE Ratio = -5.79

Quarterly (TTM)
Annual
YearPE RatioChange
20249.25-9.49%
202310.2249.35%
20226.84-65.42%
202119.79456.80%
20203.55-84.83%
201923.42-1315.19%
2018-1.93-66.68%
2017-5.79-114.82%
201639.03238.22%
201511.544.38%

Sinco Pharmaceuticals Holdings Limited (6833.HK) Average PE Ratio

How has 6833.HK PE Ratio performed in the past?

The current PE Ratio of Sinco Pharmaceuticals Holdings Limited (6833.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.77

5-year avg

9.93

10-year avg

11.59

Sinco Pharmaceuticals Holdings Limited (6833.HK) PE Ratio vs. Peers

How is 6833.HK’s PE Ratio compared to its peers?

Sinco Pharmaceuticals Holdings Limited’s PE Ratio is greater than Culturecom Holdings Limited (-6.07), greater than Joy Spreader Group Inc. (-0.32), greater than Asiaray Media Group Limited (-6.13), greater than SEEC Media Group Limited (-44.85), greater than ShiFang Holding Limited (-4.26), less than Pacific Online Limited (14.12), greater than Bright Future Technology Holdings Limited (-14.91), greater than Strawbear Entertainment Group (-7.88), greater than Duiba Group Limited (-4.55), greater than Hong Kong Economic Times Holdings Limited (-12.34),

Build a custom stock screener for Sinco Pharmaceuticals Holdings Limited (6833.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sinco Pharmaceuticals Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sinco Pharmaceuticals Holdings Limited (6833.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sinco Pharmaceuticals Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sinco Pharmaceuticals Holdings Limited's PE Ratio?

How is the PE Ratio calculated for Sinco Pharmaceuticals Holdings Limited (6833.HK)?

What is the highest PE Ratio for Sinco Pharmaceuticals Holdings Limited (6833.HK)?

What is the 3-year average PE Ratio for Sinco Pharmaceuticals Holdings Limited (6833.HK)?

What is the 5-year average PE Ratio for Sinco Pharmaceuticals Holdings Limited (6833.HK)?

How does the current PE Ratio for Sinco Pharmaceuticals Holdings Limited (6833.HK) compare to its historical average?